These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5323047)

  • 1. Azetepa--a new alkylating agent.
    McLean JA
    Isr J Med Sci; 1965 Jul; 1(4):805-7. PubMed ID: 5323047
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ixoten therapy in malignant lymphomas].
    Pötzi P; Aiginger P; Kühböck J
    Acta Med Austriaca; 1979; 6(5):247-9. PubMed ID: 400215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of the lymphomas.
    Lacher MJ
    Med Times; 1970 May; 98(5):96-102. PubMed ID: 4911076
    [No Abstract]   [Full Text] [Related]  

  • 5. "AZETEPA": A NEW ALKYLATING AGENT.
    MCLEAN JA
    Med J Aust; 1965 Apr; 1(17):620-3. PubMed ID: 14293517
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of Leo-1031 (NSC-134087) in lymphocytic lymphoma and chronic lymphocytic leukemia.
    Kaufman JH; Hanjura GL; Mittelman A; Aungst CW; Murphy GP
    Cancer Treat Rep; 1976 Mar; 60(3):277-9. PubMed ID: 946596
    [No Abstract]   [Full Text] [Related]  

  • 7. The management of generalized lymphosarcomatous disease.
    Cridland MD; Green D
    Med J Aust; 1968 Aug; 2(5):195-201. PubMed ID: 4877636
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of a new alkylating agent, azetepa, in one hundred and twenty-five cases of malignant tumors.
    Choy DS; Arandia J; Rosenbaum I
    Int J Cancer; 1967 Mar; 2(2):189-93. PubMed ID: 6039768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lycurim in the treatment of patients with chronic lymphocytic leukemia (author's transl)].
    Janicki K; Skotnicki AS; Blicharski J; Kwiatkowski A; Sliwczyńska-Dura B; Lisiewicz J
    Przegl Lek; 1980; 37(4):429-35. PubMed ID: 6996043
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of lymphomas with methyl-hydrazine (Ro 4-6467/1, MIH, "Natulanar")].
    de Oliveira HP; Atten MT
    Hospital (Rio J); 1966 Sep; 70(3):651-69. PubMed ID: 4867575
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polychemotherapy of non-Hodgkin's centrofollicular malignant lymphomas. Review of 37 cases in advanced stage (author's transl)].
    Sans-Sabrafen J; Modolell Roig A; Rosell Costa R; Boleda Relats M; Buxó Costa J; Pardo Peret P; Rodríguez Ferrera JC
    Med Clin (Barc); 1979 Oct; 73(7):267-73. PubMed ID: 388107
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in chemotherapy of lymphoma.
    Lenhard RE; Owens AH
    Johns Hopkins Med J; 1967 Aug; 121(2):136-40. PubMed ID: 5340335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hematopoietic proliferative syndromes with a semi-synthetic podophyllin derivative].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Polubiec A; Kolakowska-Polubiec K; Domańska B; Kolakowski L
    Acta Haematol Pol; 1973; 4(2):123-7. PubMed ID: 4740783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auto-immune haematological complications occurring during the treatment of malignant lymphoproliferative diseases.
    Ludwin D; Sacks P; Lynch S; Jacobs P; Bezwoda W; Bothwell TH
    S Afr Med J; 1974 Oct; 48(51):2143-5. PubMed ID: 4479692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy in non-Hodgkin lymphoma].
    Bremer K; Meusers P; Brittinger G
    Internist (Berl); 1980 Sep; 21(9):512-28. PubMed ID: 7005175
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
    Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytostatic therapy of hemoblastosis].
    Ehrhart H
    Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
    Cheson BD
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
    Marcolongo R; Bianco G; Di Paolo N; Bravi A
    Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.